{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:02:25Z","timestamp":1783702945142,"version":"3.55.0"},"reference-count":33,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation of the colonic mucosal lining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study aimed to examine unmet needs among patients with UC in Spain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Data were analyzed from the Adelphi Real World IBD Disease Specific Programme\u2122, a cross-sectional survey of physicians and patients with IBD in Spain between October 2020 and March 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Physicians reported patient clinical characteristics, disease severity, treatment patterns and satisfaction, symptoms, and flare and remission status. Patients were then invited to voluntarily self-complete a form reporting health-related quality of life (HRQoL) and work productivity\/activity impairment. Analyses were descriptive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Overall, 57 physicians reported data for 410 patients with UC presenting a high disease severity profile. The mean (standard deviation) patient age was 45 (15)\u2009years, with 88% presenting with moderate-to-severe UC at diagnosis. In the survey, 75% and 63% of patients were treated with conventional therapy and biologics, respectively. After treatment initiation, patients had lower disease severity, but 29% of patients had moderate-to-severe disease despite receiving biologics or Janus kinase inhibitors. Overall, 81% of patients and 86% of physicians were satisfied with treatment. Among patients classified as having moderate-to-severe UC, commonly reported symptoms included abdominal pain (41%), bowel urgency (37%), and bloody diarrhea (37%). The mean number of flares experienced in the past year was 1.7, lasting on average &gt;30\u2009days. Consequently, the HRQoL of these patients was impaired.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>While disease severity appeared to be lower after the initiation of current treatment, and despite the high prevalence of treatment satisfaction, almost a third of patients remained classified as moderate-to-severe, experiencing symptoms, flares, and impaired HRQoL. Therefore, there is a need for new therapeutic alternatives to target patient unmet needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562848251325190","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:48:45Z","timestamp":1743382125000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Unmet needs in adult patients with ulcerative colitis in Spain: a real-world Adelphi Disease Specific Programme study"],"prefix":"10.1177","volume":"18","author":[{"given":"Ignacio","family":"Mar\u00edn-Jim\u00e9nez","sequence":"first","affiliation":[{"name":"Hospital Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itxaso","family":"Aguirregabiria","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Avda. De la Industria, 30, Alcobendas, Madrid 28108, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"D\u00edaz-Cerezo","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Moyano","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Gabilondo","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Knight","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Harvey","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa Hunter","family":"Gibble","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Nos","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Unit, Gastroenterology Department, La Fe University and Polytechnic Hospital, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,30]]},"reference":[{"issue":"8","key":"e_1_3_4_2_2","first-page":"529","article-title":"Mechanisms of inflammatory bowel disease","volume":"9","author":"Panaccione R.","year":"2013","unstructured":"Panaccione R. Mechanisms of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2013; 9(8): 529\u2013532.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.006"},{"issue":"11","key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1080\/03007995.2021.1971180","article-title":"Ulcerative colitis: understanding the impact of ulcerative colitis on everyday life and exploring the unmet needs of patients","volume":"37","author":"O\u2019Hagan P","year":"2021","unstructured":"O\u2019Hagan P, Limdi J, Akbar A, et al. Ulcerative colitis: understanding the impact of ulcerative colitis on everyday life and exploring the unmet needs of patients. Curr Med Res Opin 2021; 37(11): 1901\u20131911.","journal-title":"Curr Med Res Opin"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2019.02.004"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00966-2"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.06.016"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.01.023"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132885"},{"key":"e_1_3_4_10_2","article-title":"La prevalencia de diez enfermedades inflamatorias inmunomediadas (IMID) en Espa\u00f1a","volume":"93","author":"Puig L","year":"2019","unstructured":"Puig L, Ruiz de Morales JG, Dauden E, et al. La prevalencia de diez enfermedades inflamatorias inmunomediadas (IMID) en Espa\u00f1a. Rev Esp Salud P\u00fablica 2019; 93: e201903013.","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30012-1"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01716-6"},{"issue":"1","key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s41687-019-0154-x","article-title":"A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis","volume":"3","author":"Newton L","year":"2019","unstructured":"Newton L, Randall JA, Hunter T, et al. A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis. J Patient Rep Outcomes 2019; 3(1): 66.","journal-title":"J Patient Rep Outcomes"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i41.5668"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab178"},{"issue":"11","key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/ibd.21237","article-title":"Ulcerative colitis in Madrid, Spain: current management","volume":"16","author":"L\u00f3pez-Serrano P","year":"2010","unstructured":"L\u00f3pez-Serrano P, P\u00e9rez-Calle JL, Fern\u00e1ndez-Rodr\u00edguez C. Ulcerative colitis in Madrid, Spain: current management. Inflamm Bowel Dis 2010; 16(11): 1826\u20131827.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"e_1_3_4_17_2","first-page":"90","article-title":"Management of acute severe ulcerative colitis in Spain: a nationwide clinical practice survey","volume":"42","author":"Rodr\u00edguez-Lago I","year":"2019","unstructured":"Rodr\u00edguez-Lago I, Ferreiro-Iglesias R, Nos P, et al. Management of acute severe ulcerative colitis in Spain: a nationwide clinical practice survey. Gastroenterol Hepatol 2019; 42(2): 90\u2013101.","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gastrohep.2020.07.001","article-title":"Gu\u00eda GETECCU 2020 para el tratamiento de la colitis ulcerosa. Elaborada con metodolog\u00eda GRADE","volume":"43","author":"Sicilia B","year":"2020","unstructured":"Sicilia B, Garc\u00eda-L\u00f3pez S, Gonz\u00e1lez-Lama Y, et al. Gu\u00eda GETECCU 2020 para el tratamiento de la colitis ulcerosa. Elaborada con metodolog\u00eda GRADE. Gastroenterol Hepatol 2020; 43: 1\u201357.","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212505"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"3108025","DOI":"10.1155\/2019\/3108025","article-title":"Unmet medical needs in the management of ulcerative colitis: results of an Italian Delphi consensus","volume":"2019","author":"Daperno M","year":"2019","unstructured":"Daperno M, Armuzzi A, Danese S, et al. Unmet medical needs in the management of ulcerative colitis: results of an Italian Delphi consensus. Gastroenterol Res Pract 2019; 2019: 3108025.","journal-title":"Gastroenterol Res Pract"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02473-6"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.2174\/1574887117666220328125720"},{"issue":"1","key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10620-016-4363-3","article-title":"Perceived emotional and psychological impact of ulcerative colitis on outpatients in Spain: UC-LIFE survey","volume":"62","author":"L\u00f3pez-Sanrom\u00e1n A","year":"2017","unstructured":"L\u00f3pez-Sanrom\u00e1n A, Carpio D, Calvet X, et al. Perceived emotional and psychological impact of ulcerative colitis on outpatients in Spain: UC-LIFE survey. Dig Dis Sci 2017; 62(1): 207\u2013216.","journal-title":"Dig Dis Sci"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802457040"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2279679"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S120101"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.082909"},{"issue":"6","key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.dld.2016.01.013","article-title":"Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: a real world-based study","volume":"48","author":"Peyrin-Biroulet L","year":"2016","unstructured":"Peyrin-Biroulet L, Van Assche G, Sturm A, et al. Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: a real world-based study. Dig Liver Dis 2016; 48(6): 601\u2013607.","journal-title":"Dig Liver Dis"},{"issue":"10","key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/MIB.0b013e31829614c6","article-title":"Abdominal pain in ulcerative colitis","volume":"19","author":"Coates MD","year":"2013","unstructured":"Coates MD, Lahoti M, Binion DG, et al. Abdominal pain in ulcerative colitis. Inflamm Bowel Dis 2013; 19(10): 2207\u20132214.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"e_1_3_4_31_2","first-page":"95","article-title":"Why studying urgency is urgent","volume":"19","author":"Pakpoor J","year":"2023","unstructured":"Pakpoor J, Travis S. Why studying urgency is urgent. Gastroenterol Hepatol (N Y) 2023; 19(2): 95\u2013100.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"6","key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ibd\/izad142","article-title":"The Communicating Needs and Features of IBD Experiences (CONFIDE) study: US and European patient and health care professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis","volume":"30","author":"Travis S","year":"2024","unstructured":"Travis S, Potts Bleakman A, Dubinsky MC, et al. The Communicating Needs and Features of IBD Experiences (CONFIDE) study: US and European patient and health care professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis. Inflamm Bowel Dis 2024; 30(6): 939\u2013949.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"e_1_3_4_33_2","article-title":"Interventions for fatigue in inflammatory bowel disease","volume":"4","author":"Farrell D","year":"2020","unstructured":"Farrell D, Artom M, Czuber-Dochan W, et al. Interventions for fatigue in inflammatory bowel disease. Cochrane Database Syst Rev 2020; 4(4): CD012005.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S175026"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848251325190","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562848251325190","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848251325190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:14:47Z","timestamp":1767687287000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562848251325190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,30]]},"references-count":33,"alternative-id":["10.1177\/17562848251325190"],"URL":"https:\/\/doi.org\/10.1177\/17562848251325190","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"value":"1756-2848","type":"print"},{"value":"1756-2848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,30]]},"article-number":"17562848251325190"}}